Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Major Adverse Cardiac Events (MACE) merupakan penyebab utama meningkatnya morbiditas dan mortalitas pada pasien sindrom koroner akut (SKA). Skor prediksi MACE merupakan model yang dapat memprediksi prognosis untuk terjadinya MACE berdasarkan faktor risiko yang dimiliki oleh pasien SKA. Tujuan: Untuk membuat skor prediksi sederhana, mudah dikalkulasi dan aplikatif, yang mampu mengidentifikasi pasien SKA dengan risiko terjadinya MACE. Metode: Dilakukan penelitian kohort retrospektif pada 1002 subyek pasien SKA yang dirawat di intensive coronary care unit RSCM dalam periode waktu Januari 2010 - Desember 2013. Dilakukan evaluasi terhadap faktor risiko jenis kelamin, usia, riwayat keluarga penyakit jantung koroner, diabetes, hemoglobin, leukosit, kreatinin, asam urat, enzim jantung, tekanan darah sistolik, denyut jantung, henti jantung, deviasi segmen ST dan kelas killip. Hasil: Major Adverse Cardiac Events didapatkan pada 112 subyek (9,21%), faktor prediktor jenis kelamin wanita, leukosit, kreatinin, asam urat, enzim jantung, tekanan darah sistolik, denyut jantung, henti jantung dan kelas killip pada analisis multivariat mempergunakan regresi logistik didapatkan berhubungan bermakna dengan MACE dengan RR (95% IK) masing-masing 2.66 (1.35-5.25), 2.06 (1.02-4.16), 2.84 (1.43-5.66), 3.79 (1.90-7.54), 3.26 (1.51-7.05), 3.48 (1.57-7.70), 2.46 (1.20-5.01), 42.04 (18.90-93.51), dan 6.31 (3.19-12.50) serta didapatkan akurasi prediksi yang baik dengan nilai area under curve 0,95, 95% IK, 0,93-0,97. Kesimpulan: Pada pasien SKA didapatkan probabilitas MACE sebesar 3,6% bagi yang memiliki skor total 0-6 dan 83,5% bagi yang memiliki skor > 6 berdasarkan faktor-faktor prediktor jenis kelamin wanita (skor 1), leukositosis (skor 1), peningkatan kreatinin (skor 1), hiperurisemia (skor 2), peningkatan enzim jantung (skor 1), hipotensi (skor 2), takikardi (skor 1), henti jantung (skor 5) dan kelas killip III-IV (skor 3).

---

Background: Major Adverse Cardiac Events (MACE) have been known as the cause of increasing morbidity and mortality among acute coronary syndrome (ACS) patients. Prediction score have been used as prognostic to prediction MACE based on risk factor in ACS patients.

Aim: To develop a simple risk score, easily calculated and applicability that can identifies ACS patients with risk for MACE.

Methods: A cohort retrospective study involving 1002 ACS patients in intensive coronary care unit RSCM from January 2010 through December 2013. Sex, age, family history, diabetes, hemoglobin, leucocyte, creatinine, uric acid, cardiac enzyme, systolic blood pressure, heart rate, cardiac arrest, deviation ST segment and killip class as risk factor for MACE was assessed.

Results: Major Adverse Cardiac Events was found in 112 (9,21%) of ACS patients, predictor factor woman, leucocyte, creatinine, uric acid, cardiac enzyme, systolic blood pressure, heart rate, cardiac arrest and killip class in multivariate logistic regression analysis were associated with MACE in ACS patients with (RR 95% CI) 2.66 (1.35-5.25), 2.06 (1.02-4.16), 2.84 (1.43-5.66), 3.79 (1.90-7.54), 3.26 (1.51-7.05), 3.48 (1.57-7.70), 2.46 (1.20-5.01), 42.04 (18.90-93.51), and 6.31 (3.19-12.50) respectively, and the best predictive accuracy for MACE was obtained by area under curve 0,95, 95% CI, 0,93-0,97.

Conclusions: In ACS patients we found probability MACE was 3,6% in patients with total score 0-6 and 83,5% for who have total score > 6 based on predictor factor woman (score 1), leukocytosis (score 1), elevated creatinine level (score 1), hyperuricemia (score 2), elevated cardiac enzyme (score 1), hypotension (score 2), tachycardia (score 1), cardiac arrest (score 5) and killip class III-IV (score 3)."

"Latar belakang. Penyakit Ginjal Kronik (PGK) stadium 3 merupakan faktor risiko tinggi terjadi Nefropati Akibat Kontras (NAK) setelah Percutaneous Coronary Intervention (PCI). Hidrasi merupakan salah satu modalitas mencegah NAK, demikian juga N-Acetyl Cysteine (NAC) walaupun efek proteksinya terhadap NAK masih kontroversial.Tujuan. Mengetahui apakah kombinasi hidrasi dan NAC dapat menurunkan risiko NAK pada pasien PGK stadium 3 setelah PCI pada pasien Pelayanan Jantung Terpadu (PJT) RSCM.Methoda penelitian. Studi kohort prospektif mengukur kreatinin plasma sebelum dan 48 jam sesudah PCI, sambil mencatat ada atau tidaknya perlakuan pemberian kombinasi hidrasi dan NAC pada pasien PGK stadium 3 tersebut.Hasil. Terdapat 38 pasien yang memenuhi kriteria penerimaan dan tidak mencakup kriteria penolakan serta menuntaskan penelitian dalam kurun waktu Agustus 2013 ? Januari 2014. Dua puluh tiga (43,4%) dari total 53 pasien PGK stadium 3 yang awalnya masuk studi ini diberikan perlakuan hidrasi dan NAC dan sisanya tidak mendapat perlakuan tersebut. Insidens kejadian NAK terdapat pada 2 dari 38 pasien yang menuntaskan studi (5.26%) yaitu pada kelompok yang tidak mendapat hidrasi dan NAC. Attributable Risk% sebesar 100%, kejadian NAK dapat dihilangkan 100% apabila diberikan hidrasi dan NAC.Simpulan. Kombinasi hidrasi dan NAC cenderung memproteksi kejadian NAKpada populasi PGK stadium 3 yang menjalani PCI

---

Background. Stage 3 Chronic Kidney Disease (CKD) is known as a high risk factor for Contrast Induced Nephropathy (CIN) after Percutaneous Coronary Intervention (PCI). Hydration is a modality which is widely used to prevent CIN, and so is N-Acetyl Cysteine (NAC) eventhough there are controversial issues regarding their effectiveness to prevent CIN.

Aim. To know whether hydration and NAC combined has an effect of lowering CIN incidence in stage 3 CKD patients after PCI in Integrated Cardiac Services (ICS) in Cipto Mangunkusumo Hospital.

Methods. A prospective cohort is conducted examining plasma creatinine before and 48 hours after PCI in stage 3 CKD patients, meanwhile recording which patients are given combined hydration and NAC and which are not.

Results. Total 38 patients were collected whom fulfill the inclusion criteria and not meet the exclusion criteria and finished the study, from August 2013 until January 2014. Twenty-three (43,4%) of total 53 patients with stage 3 CKD whom enter the study at first were given hydration and NAC, and the did not received the combination. Incidence of CIN occurred in 2 of 38 patients whom finished this study (5.26%), all belonging to the non-hydration and NAC group. Attributable Risk% is 100%, means CIN can be 100% prevented if hydration and NAC is given.

Conclusion. Combination of Hydration and NAC is indicated to be protective against the risk of CIN in stage 3 CKD patients undergoing PCI."

"Hiperlipidemia salah satu faktor resiko penyakit jantung koroner yang meningkatkan viskositas darah. Umbi kucai (Allium schoenoprasum L.) mengandung allisin yang berefek antihiperlipidemia. Penelitian bertujuan mengetahui pengaruh pemberian ekstrak etanol umbi kucai sebagai antihiperlipidemia pada tekanan darah tikus yang diinduksi diit tinggi kolesterol dan lemak. Tikus galur Sprague-Dawley sebanyak 36 ekor dibagi menjadi 6 kelompok. Semua kelompok kecuali kelompok normal diberikan diit tinggi kolesterol dan lemak. Kelompok normal, induksi, simvastatin, dosis 1, 2, dan 3 berturut-turut diberikan CMC 0,5%, CMC 0,5%, simvastatin, ekstrak umbi kucai 4,79 mg, 9,58 mg dan 19,16 mg/200g bb selama 56 hari. Tekanan darah sistol, diastol, dan tekanan arteri rata-rata diukur dengan alat pengukur tekanan darah non-invasif CODA® pada hari ke-0, ke-29 dan ke-57. Hasil analisis menunjukkan ekstrak etanol 80% umbi kucai pada dosis 9,58 mg/200g bb dapat mempengaruhi tekanan darah secara bermakna (p<0,05).

---

Hyperlipidemia is one of risk factors for coronary heart disease that increased blood viscosity. Bulb chives (Allium schoenoprasum L.) contains allicin as antihyperlipidemia. The study aimed to determine the effect of ethanol extract of blub chives as antyhiperlipidemia on rats blood pressure induced with a high dietary cholesterol and fat. Thirty six Sprague-Dawley rats were divided into 6 groups. All groups except the normal group was given a high dietary cholesterol and fat. Normal group, induction, simvastatin, dose 1, 2, and 3 respectively was given 0.5% CMC, CMC 0.5%, simvastatin, bulb chives extract 4,79 mg, 9,58 mg and 19,16 mg/200 g mm during 56 day. Systole, diastole, and mean blood pressure was measured with a non-invasive blood pressure tools from CODA® on days 0, 29th and 57th. The analysis showed the extract of bulb chives at a dose of 9,58 mg/200 g mm influence blood pressure significantly (p <0,05)."

"Latarbelakang : Defek septum atrium sekundum (DSAS) adalah salah satu penyakit kongenital yang paling sering dijumpai pada pasien anak dan dewasa. Prevalensi DSAS sebanyak 80 kasus menurut database Bedah pediatrik dan kongenital PJNHK. Salah satu morbiditas pascaoperasi penutupan DSAS yaitu LCOS. LCOS akibat dari volume overload dari atrium-ventrikel kanan dan underload pada atrium-ventrikel kiri. Hal ini mengakibatkan ventrikel kiri akan lebih smallish dibandingkan ventrikel kanan. Kurangnya volume pengisian ke ventrikel kiri yang smallish menyebabkan gangguan fungsi diastolik kiri. Setelah dilakukan penutupan DSAS, aliran darah dari atrium kiri ke atrium kanan akan berhenti dan aliran darah dari atrium kiri ke ventrikel kiri akan meningkat. ventrikel kiri yang smallish akan menerima darah lebih banyak secara tiba-tiba sehingga dapat menyebabkan gagal sirkulasi. Maka dari itu penting untuk mengetahui ukuran volume ventrikel kiri sebelum dilakukan penutupan DSAS untuk menghindari LCOS. MRI merupakan pemeriksaan gold standar untuk mengukur volume ventrikel. Metode : Dilakukan studi kohort retrospektif pada pasien DSAS yang berumur >5 tahun yang memilikidata preoperasi MRI LVEDVi untuk menilai volume ventrikel kiri periode waktu Januari 2018-Desember 2019. Analisis bivariat menggunakan uji student t-test tidak berpasangan. Uji diagnostik menggunakan ROC untuk mendapatkan nilai AUC. Penentuan cut-off point berdasarkan nilai sensitivitas dan spesifisitas yang seimbang kemudian dinilai positive predictive value dan negatif predictive value. Hasil : Terdapat 62 subjek dari penelitian ini Subjek yang mengalami kejadian LCOS di ICU mempunyai rerata LVEDVi 45±7,42mL/m2. Subjek yang tidak mengalami kejadian LCOS rerata LVEDVi 64,15±13,37mL/m2 (p< 0,001). Nilai AUC 96% (95% CI: 92-100%). Nilai cut off LVEDVi terbaik terhadap kejadian LCOS pascaoperasi penutupan DSAS yaitu ≤53,3mL/m2. Memiliki sensitivitas 87,1%, spesifisitas 87,1%, positive predictive value 87,1%, negative predictive value 87,1% dan diagnostic accuracy 87,1%. Simpulan : LVEDVi terbukti dapat dijadikan prediktor kejadian LCOS pascaoperasi penutupan DSAS dengan titik potongyang baik.  Nilai cut off LVEDVi terbaik terhadap kejadian LCOS pascaoperasi penutupan DSAS yaitu 53,3mL/m2.

---

Background : SecundumAtrial Septal Defect (ASD) is one of the most common congenital diseases in pediatric and adult patients. The prevalence of secundum ASDis 80 cases according to the NCCHKPediatric and Congenital Surgery database. One of the postoperative morbidity of secundum ASDclosure is LCOS. LCOS results from volume overload from the right atrium-ventricle and underload in the left atrium-ventricle. This results in the left ventricle being smaller than the right ventricle. The lack of filling volume to the smallish left ventricle causes impaired left diastolic function. After secundum ASDclosure, blood flow from the left atrium to the right atrium will stop and blood flow from the left atrium to the left ventricle will increase. The smallish left ventricle will receive more blood suddenly so that it can cause circulation failure. Therefore it is important to know the size of the left ventricular volume before secundum ASDclosure to avoid LCOS. MRI is a gold standard examination to measure ventricular volume. Method : A retrospective cohort study was performed on secundum ASDpatients aged >5 years who had MRI LVEDVi preoperative data to assess the volume of the left ventricle during the January 2018-December 2019 period. Bivariate analysis usingan unpaired student t-testwas done. Diagnostic test uses ROC to get the AUC value. Determination of cut-off points was done based on balanced sensitivity and specificity values, after that we assesspositive predictive value and negative predictive value. Results : There were 62 subjects from this study. Subjects who experienced the occurrence of LCOS in the ICU had an average LVEDVi 45±7,42mL/m2. Subjects who did not experience an LCOShad an averageLVEDVi 64,15±13.37mL/m2 (p <0.001). AUC value of 96% (95%CI: 92-100%). The best LVEDVi cut off value for the incidence of LCOSpostoperative secundum ASDclosureis ≤53.3mL/m2.Ithas a sensitivity of 87,1%, specificity 87,1%, positive predictive value 87,1%, negative predictive value 87,1% and diagnostic accuracy 87,1%. Conclusion : LVEDVi is proven to be a predictor of the occurrence of LCOS events postoperative secundum ASDclosure with good cut points. The best LVEDVi cut off value for the occurrence of LCOS events postoperativesecundum ASDclosure is 53,3 mL/m2."

"Coronary Artery Disease CAD merupakan kondisi ketidakseimbangan suplai dan kebutuhan oksigen miokardial yang disebabkan oleh berbagai faktor sehingga terapi yang diberikan berupa kombinasi obat. Penggunaan kombinasi obat meningkatkan terjadinya interaksi obat. Penelitian ini bertujuan untuk menganalisis potensi interaksi obat kombinasi golongan nitrat dan calcium channel blocker CCB dengan obat lain pada pasien CAD rawat jalan di RSUD Pasar Minggu tahun 2017. Desain penelitian ini adalah cross-sectional dengan pengambilan data retrospektif. Sampel yang memenuhi kriteria inklusi sebanyak 167 resep. Kejadian interaksi obat diperiksa menggunakan Micromedex. Hasil menunjukkan bahwa terdapat 142 resep yang memiliki potensi interaksi. Potensi interaksi terbanyak terjadi dengan tingkat keparahan mayor 62,2, diikuti keparahan moderat 33,8. Obat yang paling banyak menimbulkan interaksi adalah kombinasi amlodipin dengan simvastatin. Kesimpulan dari penelitian ini adalah penggunaan kombinasi nitrat dan CCB dengan obat lain pada pasien CAD berpotensi menyebabkan interaksi, sehingga perlu disarankan melakukan pemeriksaan laboratorium secara berkala atau penyesuaian rejimen dosis untuk meminimalisasi terjadinya interaksi.

---

Coronary Artery Disease CAD is imbalances of supply and demand of myocardial oxygens which is caused by multiple factors, thus requires drug combinations as therapy. The use of such drug combinations may increase the incidence of drug interactions. This study aim is analyze the potentials of drug combinations between nitrate and CCB category with other drugs on outpatients with CAD at Pasar Minggu General Hospital in 2017. Design of this study is cross sectional with retrospective data collection. Samples which corresponds to inclusion criteria are 167 prescriptions. The occurrence of drug interactions are checked using Micromedex . Result showed that there were 142 prescriptions with potentials of interactions. The largest potential in drug interactions occur in major severity 62,23 followed by moderate severity 33,77. The drug that causes drug interactions the most is combination of amlodipin and simvastatin. This study concluded that the use of nitrate and CCB drug combinations with other drugs has the potential to cause interactions, therefore periodic laboratory checkups needs or adjustment of dosage regimen to be recommended to minimize the incidence of drug interactions. "

"Penyakit jantung bawaan (PJB) merupakan salah satu masalah yang perlu mendapatkan perhatian khusus. Diperlukan sarana pelayanan yang memadai serta terjangkau di masyarakat. Laboratorium kateterisasi merupakan salah satu sarana penting sebagai diagnostik dan intervensi, khususnya untuk PJB. Tingginya kebutuhan pelayanan unit ini menuntut utilisasi yang optimal. Utilisasi yang tidak efisien akan memperlama waktu tunggu tindakan, memperboros sumber daya, dan berpotensi pada pemburukan klinis pasien. Utilisasi adalah salah satu indikator non klinik di kamar operasi. Di laboratorium kateterisasi Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita (RSJPDHK), utilisasi menjadi salah satu target indikator mutu pelayanan. Penelitian ini bertujuan untuk melihat utilisasi laboratorium kateterisasi pediatrik dan faktor-faktor yang berhubungan dengan hal tersebut. Dengan mengetahui utilisasi, dapat diperoleh gambaran mengenai efisiensi ruangan tersebut. Jenis penelitian ini adalah kombinasi kuantitatif dan kualitatif yang telah dilaksanakan pada Juni 2022. Data primer diperoleh melalui wawancara mendalam terhadap stakeholder yang berhubungan langsung dengan kebijakan dan implementasi unit pelayanan, sedangkan data sekunder didapatkan melalui catatan register unit, rekam medis, regulasi, dan dokumen objek penelitian lainnya berdasarkan variabel mulai prosedur pertama, jeda waktu antar tindakan, waktu selesai prosedur terakhir, dan jumlah pasien harian. Variabel tersebut juga dianalisis dari sisi Standar Prosedur Operasional (SPO), Sumber Daya Manusia (SDM), dan fasilitas. Hasil penelitian ini menunjukkan angka utilisasi 81,21%, melebihi target bila diukur menurut indikator mutu RSJPDHK. Faktor-faktor yang berhubungan, antara lain jumlah prosedur harian, jenis prosedur, dan waktu selesai prosedur terakhir (p-value < 0,05). Kesimpulan penelitian ini adalah utilisasi unit ini masih perlu ditingkatkan dan target utilisasi 70% atau tujuh jam per hari perlu ditinjau ulang untuk ditingkatkan agar menampung jumlah prosedur yang lebih banyak dan mengurangi waktu tunggu pasien. Sebagai saran, perlu perubahan sistem pengaturan pelaksanaan tindakan, mulai dari sistem penjadwalan, jumlah dan pengelompokan prosedur harian, revisi shift kerja non medis, hingga evaluasi berkala target utilisasi ruang kateterisasi pediatrik.

---

Congenital heart disease (CHD) is a disease that requires special attention. Consequently, adequate facilities and affordable services for the general public are necessary. Catheterization laboratories are essential facilities in performing diagnosis and intervention, especially for CHD. The high demand for service of these units demands optimal utilization. Inefficient utilization will prolong waiting time, waste resources, and potentially worsen patients' clinical condition. Utilization is a non-clinical indicator in operating theatres. In the catheterization laboratory at Harapan Kita Heart and Vascular Hospital (RSJPDHK), utilization is one of the target indicators for service quality. This study aimed to examine the utilization of the pediatric catheterization laboratory and its related factors. By understanding its utilization, a better overview of room efficiency can be obtained. The research combined quantitative and qualitative methods and was carried out in June 2022. Primary data were obtained through in-depth interviews with relevant stakeholders who were directly related to the policy and implementation of service units. Secondary data were acquired through unit register records; medical records; regulations and research object documents; other variables based on the start of the first procedure; the time lag between procedures; the time of completion of the last procedure; and the number of daily patients. These variables were also analyzed in terms of standard operating procedures (SPO), human resources (HR), and facilities. The study results indicated a utilization rate of 81.21%, which exceeds the target based on the RSJPDHK quality indicators. The related factors included the number of daily procedures, the type of procedure, and the time of the last procedure (p-value <0.05). This study concludes that the utilization of the unit still requires further enhancement, and the utilization target of 70% or seven hours per day needs to be reviewed to accommodate a greater number of procedures and reduce patient waiting time. We suggest changes to the regulatory system for the implementation of several initiatives, including the scheduling system, the number and grouping of daily procedures, the revision of non-medical work shifts, as well as periodic evaluations of pediatric catheterization room utilization targets."

"Myocardial infarction is the greatest single cause of premature death in the western world. This concise and practical volume is directed at doctors and nurses working in coronary care units (CCU) where patients suspected of myocardial infarction are managed. Evidence-based footnotes are included throughout, providing data from clinical trials on which some of the therapies and management strategies are based. A useful appendix enables the physician to rapidly calculate a patients 10 year coronary risk. It will be an invaluable guide to the assessment and management of cardiac patients from admission to A&E, during their stay in the CCU, but also after transfer to a recovery area and discharge home."

"Myocardial infarction is the greatest single cause of premature death in the western world. This concise and practical volume is directed at doctors and nurses working in coronary care units (CCU) where patients suspected of myocardial infarction are managed. Evidence-based footnotes are included throughout, providing data from clinical trials on which some of the therapies and management strategies are based. A useful appendix enables the physician to rapidly calculate a patients 10 year coronary risk. It will be an invaluable guide to the assessment and management of cardiac patients from admission to A&E, during their stay in the CCU, but also after transfer to a recovery area and discharge home."

"A guide to using alternative medicine in a safe, effective manner to prevent & treat America's number-one killer disease.The authors show how to use alternative medicine in conjunction with traditional medical treatment to reverse heart disease. They include practical, how-to instructions for using each therapy discussed."